SusanLernerCohnMD

Pediatric Hematology & Oncology • Chicago, IL

Pediatric Solid Tumor Oncology

Professor of Pediatrics, University of Chicago Medicine

Join to view full profile

Dr. Cohn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cohn's full profile

Already have an account?

Office
900 E 57th Street
KCBD Rm 5100
Chicago, IL 60637
Phone(773) 702-6808
Is this information wrong?

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1984 - 1987
Michael Reese Hospital and Medical CenterResidency, Pediatrics, 1980 - 1984
University of Illinois College of MedicineClass of 1980
Northwestern UniversityB.A., 1972 - 1976

Certifications & Licensure

IL State Medical License 1981 - 2023
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Cancer Doctor Newsweek and Castle Connolly, 2015-2020
Top Doctor in the Chicago Metro Area Castle Connolly, 2005-2020
Top Doctor in the Chicago Metro Area Chicago Magazine, 2005-2020
AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research AACR, 2019
The Samuel Spector Award for Mentorship Department of Pediatrics, University of Chicago, 2018
Pediatric Oncology Award American Society of Clinical Oncology (ASCO), 2016
Fellow American Society of Clinical Oncology (FASCO), 2016
American Society of Clinical Oncology (ASCO) Pediatric Oncology Award ASCO, 2016
Pediatrics Faculty Physician Peer Role Model Nominee University of Chicago, 2013
Pritzker Scholar University of Chicago, 2012
Chicago Innovator Award Association for Women in Science (AWIS), 2012
Joseph P. Brenneman Award The Chicago Pediatric Society, 2009
SIOP Award in the Discipline of Basic Science Society for Industrial and Organizational Psychology, Inc., 2004
Nominated for the best clinical professor award Northwestern University Medical School, 1999
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat Start of enrollment: 2014 Jul 01Marachelian, A.,Twist, C.,Yanik, G.,Park, J.,Matthay, K.,Goldsmith, K.,Macy, M.,Granger, M.,Roberts, S.,DuBois, S.,Cohn, S.L.,Shusterman, S.,Baruchel, S.,Mosse, Y.
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan Start of enrollment: 2013 Dec 01Marachelian, A.,Marchelian, A.,Weiss, B.,Twist, C.,Yanik, G.,Park, J.R.,Matthay, K.,Goldsmith, K.,Macy, M.,Granger, M.,Kreissman, S.,Cohn, S.L.,Shusterman, S.-.,Mosse, Y.
A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients With Refractory/Recurrent Neuroblastoma Start of enrollment: 2013 Feb 01Macy, M.,Park, J.R.,Matthay, K.K.,Granger, M.M.,Twist, C.,Mosse, Y.P.,Marachelian, A.,Weiss, B.D.,Roberts, S.S.,Yanik, G.A.,Shusterman, S.,Cohn, S.L.
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 01Chen, A.R.,Bedros, A.A.,El-Sheikh, A.A.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Bostrom, B.C.,Michon, B.,Appel, B.E.,Lenarsky, C.,Rodriguez-Galindo, C.,Portwine, C.,Arndt, C.A.,Strahlendorf, C.,Cole, C.H....
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01Abish, S.B.,Atkinson, M.M.,Barnette, P.E.,Bernstein, J.,Bonilla, M.A.,Broxson, E.H.,Burke, M.J.,Calderwood, S.,Chauvenet, A.R.,Cole, C.H.,Cooper, R.M.,Cooper, T.M.,Croop, J.M.,Crouse, V.L.,Estrada, J.,Fel...
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 01Esbenshade, A.,Levy, A.,Levy, A.S.,Homans, A.C.,Lee, A.,Reddy, A.T.,Hayani, A.,Rao, A.A.,Warwick, A.B.,Bedros, A.A.,Khan, A.,Sleckman, B.G.,Bostrom, B.C.,Michon, B.,Appel, B.E.,Lenarsky, C.,Strahlendorf, ...
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Start of enrollment: 2010 Oct 01Reddy, A.T.,Weiss, B.D.,Weiss, B.,Rodriguez-Galindo, C.,Hawkins, D.S.,Kraveka, J.M.,Dome, J.S.,Boklan, J.,Felgenhauer, J.L.,Matthay, K.K.,DeSantes, K.B.,Mascarenhas, L.,Browning, M.B.,Isakoff, M.S.,Winick...
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 01Homans, A.C.,Aledo, A.,Chauvenet, A.R.,Reddy, A.T.,Termuhlen, A.M.,Hayani, A.,Angiolillo, A.,Cairney, A.E.,Angiolillo, A.L.,Langevin, A.R.,Bedros, A.A.,Redner, A.S.,Ritchey, A.K.,Shad, A.T.,Razzouk, B.I.,...
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 01Homans, A.C.,Aledo, A.,Reddy, A.T.,Hayani, A.,Pawlowska, A.B.,Warwick, A.B.,Cairney, A.E.,Langevin, A.R.,Bedros, A.A.,Redner, A.S.,Ritchey, A.K.,El-Sheikh, A.A.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Mik...
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 Mar 01Esbenshade, A.,Chauvenet, A.R.,Reddy, A.T.,Termuhlen, A.M.,Rao, A.A.,Smith, A.A.,Warwick, A.B.,Langevin, A.R.,Bedros, A.A.,Banerjee, A.,Ritchey, A.K.,Khan, A.,El-Sheikh, A.A.,Razzouk, B.I.,Sleckman, B.G.,...
Vorinostat With 131-I MIBG Therapy for Resistant/Relapsed Neuroblastoma: A Phase I Study IND# 105,744 Start of enrollment: 2010 Mar 01Cohn, S.L.,DuBois, S.,Granger, M.,Katzenstein, H.,Kreissman, S.,Marachelian, A.,Matthay, K.K.,Mosse, Y.,Park, J.R.,Shusterman, S.,Twist, C.,Weiss, B.,Yanik, G.,Zage, P.
A Phase I Study of Bevacizumab With Bolus and Metronomic Cyclophosphamide and Zoledronic Acid in Children With Recurrent or Refractory Neuroblastoma Start of enrollment: 2009 Dec 01Baruchel, S.,Cohn, S.L.,Glade-Bender, J.,Glade-Bender, J.L.,Granger, M.,Katzenstein, H.,Kreissman, S.,Marachelian, A.,Matthay, K.K.,Mosse, Y.,Park, J.R.,Shusterman, S.,Teira, P.,Twist, C.,Weiss, B.,Yanik,...
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01Lee, A.,Reddy, A.T.,Termuhlen, A.M.,Hayani, A.,Warwick, A.B.,Langevin, A.R.,Bedros, A.A.,Ritchey, A.K.,El-Sheikh, A.A.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Kitchen, B.J.,Weigel, B.J.,Wittman, B.J.,Gref...
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01Lee, A.,Reddy, A.T.,Termuhlen, A.M.,Hayani, A.,Warwick, A.B.,Langevin, A.R.,Bedros, A.A.,Ritchey, A.K.,El-Sheikh, A.A.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Kitchen, B.J.,Weigel, B.J.,Wittman, B.J.,Gref...
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2008 Sep 01Chauvenet, A.R.,Reddy, A.T.,Langevin, A.R.,Banerjee, A.,El-Sheikh, A.A.,Razzouk, B.I.,Sleckman, B.G.,Bostrom, B.C.,Appel, B.E.,Lenarsky, C.,Rodriguez-Galindo, C.,Portwine, C.,Arndt, C.A.,Strahlendorf, C.,...
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 01Homans, A.C.,Lee, A.,Chauvenet, A.R.,Reddy, A.T.,Termuhlen, A.M.,Hayani, A.,Langevin, A.R.,Bedros, A.A.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Wistinghausen, B.,Weigel, B.J.,Bostrom, B.C.,Michon, B.,Appe...
A Phase I Study of Intravenous (Emulsion) Fenretinide in Children With Recurrent or Resistant Neuroblastoma Start of enrollment: 2006 Dec 01Baruchel, S.,Blaney, S.M.,Cohn, S.L.,Glade-Bender, J.L.,Katzenstein, H.M.,Maris, J.M.,Maurer, B.J.,Park, J.R.,Reynolds, C.P.,Twist, C.,Villablanca, J.G.
Study of Kidney Tumors in Young Patients Start of enrollment: 2006 Feb 01Homans, A.C.,Friedman, A.D.,Aledo, A.,Lee, A.,Chauvenet, A.R.,Reddy, A.T.,Warwick, A.B.,Cairney, A.E.,Langevin, A.R.,Bedros, A.A.,Redner, A.S.,Ritchey, A.K.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Wisting...
Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder in Patients With Recurrent or Resistant Neuroblastoma Start of enrollment: 2005 Dec 01Cohn, S.L.,Glade-Bender, J.L.,Katzenstein, H.M.,Maris, J.M.,Matthay, K.K.,Maurer, B.J.,Park, J.R.,Perentesis, J.P.,Russell, H.V.,Shusterman, S.,Sondel, P.M.,Twist, C.,Villablanca, J.G.
Study of Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 01Homans, A.C.,Lee, A.,Chauvenet, A.R.,Reddy, A.T.,Hayani, A.,Cairney, A.E.,Langevin, A.R.,Ritchey, A.K.,El-Sheikh, A.A.,Razzouk, B.I.,Bostrom, B.C.,Lenarsky, C.,Golden, C.B.,Rodriguez-Galindo, C.,Portwine,...
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Mar 01Homans, A.C.,Lee, A.,Reddy, A.T.,Termuhlen, A.M.,Bedros, A.A.,Redner, A.S.,Ritchey, A.K.,Razzouk, B.I.,Wistinghausen, B.,Bostrom, B.C.,Appel, B.E.,Lenarsky, C.,Golden, C.B.,Rodriguez-Galindo, C.,Portwine,...
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 01Yu, A.L.,Lee, A.,Yu, A.,Chen, A.R.,Reddy, A.T.,Pawlowska, A.B.,Cairney, A.E.,Bedros, A.A.,Redner, A.S.,El-Sheikh, A.A.,Mikles, B.M.,Wistinghausen, B.,Wittman, B.J.,Greffe, B.S.,Michon, B.,Appel, B.E.,Lena...
Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) Autologous Stem Cell Support for Resistant or Recurrent High-Risk Neuroblastoma (IND 69-112) Start of enrollment: 2001 Aug 01Baruchel, S.,Cohn, S.L.,Marachelian, A.,Matthay, K.K.,Mosse, Y.,Park, J.R.,Shusterman, S.-.,Teira, P.,Volchenboum, S.,Weiss, B.
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 01Homans, A.C.,Lee, A.,Chauvenet, A.R.,Chen, A.R.,Reddy, A.T.,Termuhlen, A.M.,Hayani, A.,Pawlowska, A.B.,Warwick, A.B.,Cairney, A.E.,Langevin, A.R.,Bedros, A.A.,Redner, A.S.,El-Sheikh, A.A.,Razzouk, B.I.,Sl...
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 01Homans, A.C.,Chauvenet, A.R.,Reddy, A.T.,Termuhlen, A.M.,Warwick, A.B.,Cairney, A.E.,Langevin, A.R.,Bedros, A.A.,Redner, A.S.,Ritchey, A.K.,Ozsahin, A.H.,Shad, A.T.,Razzouk, B.I.,Sleckman, B.G.,Wistinghau...
Join now to see all

Publications & Presentations

PubMed

Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
Wayne H. Liang, Sara M. Federico, Wendy B. London, Arlene Naranjo, Meredith S. Irwin, Samuel L. Volchenboum, Susan L. Cohn> ;JCO clinical cancer informatics. 2020 Oct 15
Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer.
Jennifer W. Mack, Hajime Uno, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, M. Meaghan Granger, Julia Glade Bender, Justin N. Baker, Julie R....> ;Journal of Pain and Symptom Management. 2020 Oct 1
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Erin K. Barr, Kathryn Laurie, Kristen Wroblewski, Mark A. Applebaum, Susan L. Cohn> ;Pediatric Blood & Cancer. 2020 Jul 25
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
Karyn Gerstle, Amir Bari Siddiqui, Jefree J. Schulte, Susan L. Cohn> ;Pediatric Blood & Cancer. 2020 May 30
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project
Veronica Moroz, David Machin, Barbara Hero, Ruth Ladenstein, Frank Berthold, Paige Kao, Yaa Obeng, Andrew D.J. Pearson, Susan L. Cohn, Wendy B. London> ;Pediatric Blood & Cancer. 2020 May 30
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project
Elizabeth A. Sokol, Ami V. Desai, Mark A. Applebaum, Dominique Valteau-Couanet, Julie R. Park, Andrew D.J. Pearson, Gudrun Schleiermacher, Meredith S. Irwin, Michael D...> ;Journal of Clinical Oncology. 2020 Apr 21
Unrealistic parental expectations for cure in poor‐prognosis childhood cancer
Jennifer W. Mack, Angel M. Cronin, Hajime Uno, Suzanne Shusterman, Clare J. Twist, Rochelle Bagatell, Abby R. Rosenberg, Araz Marachelian, M. Meaghan Granger, Julia Gl...> ;Cancer. 2020 Jan 15
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim anal...
Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, Lynley V. Marshall, Catherine Vezina, Alberto S. Pappo, Theodore W. Laetsch, Antonio Sergio Petrilli, Martin Ebing...> ;Lancet Oncology. 2020 Jan 1
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
Mark A. Applebaum, Erin K. Barr, Jason Karpus, Diana C. West-Szymanski, Meritxell Oliva, Elizabeth A. Sokol, Sheng Zhang, Zhou Zhang, Wei Zhang, Alexandre Chlenksi, He...> ;Clinical Cancer Research. 2019 Dec 18
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Julie R. Park, Susan G. Kreissman, Wendy B. London, Arlene Naranjo, Susan L. Cohn, Michael D. Hogarty, Sheena C. Tenney, Daphne A. Haas-Kogan, Peter J. Shaw, Jacquelin...> ;JAMA. 2019 Aug 27
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
Steve Braunstein, Wendy B. London, Susan G. Kreissman, Judith G. Villablanca, Andrew M. Davidoff, Kenneth B. DeSantes, Robert P. Castleberry, Kevin Murray, Lisa Diller...> ;Pediatric Blood & Cancer. 2019 Jul 1
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype
Mark A. Applebaum, Erin K. Barr, Jason Karpus, Ji Nie, Zhou Zhang, Amy E. Armstrong, Sakshi Uppal, Madina Sukhanova, Wei Zhang, Alexandre Chlenski, Helen R. Salwen, Em...> ;JCO precision oncology. 2019 May 16
The challenge of defining "ultra-high-risk" neuroblastoma.
Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Domi...> ;Pediatric Blood & Cancer. 2019 Apr 1
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Alexandre Chlenski, Chanyoung Park, Marija Dobratic, Helen R. Salwen, Brian Budke, Jae-Hyun Park, Ryan Miller, Mark A. Applebaum, Emma Wilkinson, Yusuke Nakamura, Phil...> ;Molecular Cancer Therapeutics. 2019 Mar 1
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
Elizabeth A. Sokol, Roger Engelmann, Wenjun Kang, Navin Pinto, Adam Starkey, Hollie Lai, Helen Nadel, Barry L. Shulkin, Yonglin Pu, Daniel Appelbaum, Gregory A. Yanik,...> ;Pediatric Blood & Cancer. 2018 Dec 1
Data Commons to Support Pediatric Cancer Research.
Volchenboum SL, Cox SM, Heath A, Resnick A, Cohn SL, Grossman R> ;American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting.
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System
Arlene Naranjo, Meredith S. Irwin, Michael D. Hogarty, Susan L. Cohn, Julie R. Park, Wendy B. London> ;JCO clinical cancer informatics. 2018 Jul 20
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.
Chen, L., Humphreys, A., Turnbull, L., Bellini, A., Schleiermacher, G., Salwen, H. R., Cohn, S. L., Bown, N., Tweddle, D. A.> ;Oncotarget. 2016 Nov 27
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
Navin Pinto, Jodi R. Mayfield, Gordana Raca, Mark A. Applebaum, Alexandre Chlenski, Madina Sukhanova, Rochelle Bagatell, Meredith S. Irwin, Anthony Little, Jawhar Raww...> ;Pediatric Blood & Cancer. 2016 Jun 1
46 citations
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin Pinto, Mark A. Applebaum, Samuel L. Volchenboum, Katherine K. Matthay, Wendy B. London, Peter F. Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher,...> ;Journal of Clinical Oncology. 2015 Sep 20
A Selfless Act
Susan Cohn, MD> ;Journal of Clinical Oncology. 2015 Aug 12
3 citations
Surveillance of Childhood Cancer Survivors: A Lifelong Affair
Mark A. Applebaum, Susan L. Cohn> ;Journal of Clinical Oncology. 2015 Aug 10
Integrating Cell‐Based and Clinical Genome‐Wide Studies to Identify Genetic Variants Contributing to Treatment Failure in Neuroblastoma Patients
Navin Pinto, Eric R. Gamazon, Nirav N. Antao, Jamie Myers, Amy L. Stark, Anuar Konkashbaev, Hae Kyung Im, Sharon J. Diskin, Wendy B. London, Susan M. Ludeman, John M. ...> ;Clinical Pharmacology & Therapeutics. 2014 Jun 1
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0...
Clare J. Twist, Mary Lou Schmidt, Arlene Naranjo, Wendy B. London, Sheena C. Tenney, Araz Marachelian, Hiroyuki Shimada, Margaret H. Collins, Natia Esiashvili, E. Stan...> ;Journal of Clinical Oncology. 2014 May 20
12 citations
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
Thomas Stricker, Andres Morales La Madrid, Alexandre Chlenski, Lisa J. Guerrero, Helen R. Salwen, Yasmin Gosiengfiao, Elizabeth J. Perlman, Wayne L. Furman, Armita Bah...> ;Molecular Oncology. 2014 May 1
Join now to see all

Journal Articles

Children's Oncology Group's 2013 blueprint for research: neuroblastoma
Park JR, Bagatell R, London WB, Maris JM, Cohn SL, Mattay KM, Hogarty M; COG Neuroblastoma Committee, Pediatr Blood Cancer, 1/1/2013
Two Cases of Localized Neuroblastoma with Multiple Segmental Chromosomal Alterations and Metastatic Progression
Morales La Madrid A, Nall MB, Ouyang K, Minor A, Raca G, Kent P, Miller I, Schleiermacher G, Janoueix-Lerosey I, and Cohn SL, Ped Blood Cancer, 1/1/2013
Progression-Free Survival of Two Cases of High-risk Neuroblastoma with Refractory/Relapsed Disease Following Surgery Alone
Sokol E, Haut PR, Gosiengfiao Y, Feinstein K, Pytel P, and Cohn SL, Ped Blood Cancer, 1/1/2013
Semiquantitative MIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma A Children's Oncology Group (COG) Study
Yanik GA, Parisi MT, Shulkin BL, Naranjo A, Kreissman SG, London WB, Villablanca J, Maris J, Cohn SL, McGrady P, Matthay KK, J Nucl Med, 1/1/2013
A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children's Oncology Group study ANBL00P1
Seif AE, Naranjo A, , Baker DL, Bunin NJ, Kletzel M, Kretschmar CS, Maris JM, McGrady PW, von Allmen D, Cohn SL, London WB, Park JR, Diller LR, Grupp SA, Bone Marrow Transplant, 1/1/2013
Neuroblastoma - Undifferentiated Subtype, Prognostic Significance of Prominent Nucleolar Formation and Expression of MYC and MYCN Protein: A Report from the Children's...
Wang LL, Suganunma R, Ikegaki N, Tang X, Naranjo A, McGrady P, London WB, Hogarty MB, Gastier-Foster J, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, and Shimada H, Cancer, 1/1/2013
A Randomized Trial of Purged versus Non-Purged Autologous Peripheral Blood Stem Cell Transplant for High-Risk Neuroblastoma
Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, LaQuaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, an..., Lancet Oncol, 1/1/2013
Individualized Therapies for Pediatric Cancer
Bates S, Thiele C, Cohn S, Clinical Cancer Research FOCUS, 5/18/2012
New Aspects of Neuroblastoma Treatment: ASPHO 2011 Symposium Review
Zage PE, Louis CU, and Cohn SL, Pediatr Blood Cancer, 1/1/2012
Genetically InFormed Therapies- a GIFT for children with cancer
Thiele CJ and Cohn SL, Clin Cancer Res, 1/1/2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
Morales La Madrid A, Campbell N, Smith S, Cohn SL, and Salgia R, Target Oncol, 1/1/2012
Opsoclonusmyoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma
Morales LaMadrid A, Rubin CM, Kohrman M, Pytel P, and Cohn SL, Pediatr Blood Cancer, 1/1/2012
Sorafenib Inhibits Neuroblastoma Cell Proliferation and Signaling, Blocks Angiogenesis, and Impairs Tumor Growth
Kakodkar NC, Peddinti RR, Tian Y, Guerrero LJ, Chlenski A, Yang Q, Salwen HR, Maitland M, and Cohn SL, Ped Blood Cancer, 1/1/2012
Outcome Following Surgery Alone or with Restricted Use of Chemotherapy for Patients with Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
Strother DR, London WB, Schmidt ML, Brodeur G et al for the Children's Oncology Group, J Clin Oncol, 1/1/2012
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma
Ostler KR, Yang Q, Looney TJ, et al, Cancer Res, 1/1/2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM et al, Br J Cancer, 1/1/2012
A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants, a Children's Oncology Group Study
Nuchtern JG, London WB, Barnewolt CE,Naranjo A, McGrady, Geiger JD, Cohn SL, Shamberger RC, Ann Surg, 1/1/2012
Locoregional MYCN-amplified Neuroblastoma: Case Report and Review of the Literature
Morales La Madrid A, Volchenboum S, Gastier-Foster JM, Pyatt R, Liu D, Pytel P, Lavarino C, Rodriguez E, and Cohn SL, Ped Blood Cancer, 1/1/2012
Advances in Pediatric Oncology
Cohn SL, SoCRA Source, 1/1/2011
Phase II Study of Irinotecan + Temozolomide in Children with Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
Bagatell R, London WB, Wagner LM, Voss S, Reynolds CP, Stewart C, Gelfand M, Maris JM, Kretschmar C, Cohn SL, J Clin Oncol, 1/1/2011
Racial and Ethnic Disparities in Risk and Survival in Children with Neuroblastoma: A Children's Oncology Group (COG) Study
Henderson TO, Bhatia S, Pinto N, London WB, McGrady P, Crotty C, Sun C-L, and Cohn SL, J Clin Oncol, 1/1/2011
Changes over three decades in the prognostic influence of age in patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson ADJ, Cohn SL, an..., Eur J Cancer, 1/1/2011
Radiological Guidelines for Staging of Neuroblastic Tumors: A consensus Report from the Imaging Committee of the International Neuroblastoma Risk Group Project
Brisse H, McCarville B, Granata C, Kanegawa K, Krug B, Wooton-Gorges S, Giamarile F, Levington V, Shulkin B, Kaneko M, Monclari T, Sarnacki S, Cohn SL, Hero B, Matthay..., Radiology, 1/1/2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group (INRG) Project
London WB, Castel V, Monclair T, Ambros PF, Pearson ADJ, Cohn SL, Berthold F, Nakagawara A, Ladenstein RL, Iehara T, and Matthay KK, J Clin Oncol, 1/1/2011
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
Henderson MJ, Haber M, Porro A, Munoz MA, Iraci N, Xue, C, Murray J et al, J Natl Cancer Res, 1/1/2011
Join now to see all

Grant Support

Pediatric Cancer Data CommonsSt. Baldrick’s Foundation2019–2025
Targeting DNA Double Strand Break (DSB) Repair Pathways in NeuroblastomaHyundai Hope on Wheels2020–2022
ITM 2.0: Advancing Translational Science in Metropolitan ChicagoNIH/NCATS2017–2022
5-hydroxymethylcytosine-based Biomarkers for Children with NeuroblastomaThe Super Jake Foundation2019–2021
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell Free DNAAlex's Lemonade Stand Foundation2017–2019
MELK, A New Therapeutic Target for NeuroblastomaHyundai Hope on Wheels2017–2019
Children's Oncology GroupNCI2012–2019
The Role Of Sparc In Neuroblastoma AngiogenesisNational Institute Of Neurological Disorders And Stroke2007
The Role Of Sparc In Neuroblastoma AngiogenesisNational Institute Of Neurological Disorders And Stroke2004–2006
Pediatric Oncology GroupNational Cancer Institute1999–2002
Elav-Like Proteins In NeuroblastomaNational Cancer Institute1997–2000
Molecular Mechanisms Of Differentiation In NeuroblastomaNational Cancer Institute1990–1994